id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1998-N-1001-0010,FDA,FDA-1998-N-1001,Response Letter from FDA CDER to Cumulus Pharmaceutical LL (Carbomer),Other,Response(s),2022-09-13T04:00:00Z,2022,9,2022-09-13T04:00:00Z,,2022-09-13T16:07:23Z,,0,0,09000064852f8d90
FDA-1998-N-1001-0009,FDA,FDA-1998-N-1001,Response Letter from FDA CDER to Cumulus Pharmaceutical LLC (Dexpanthenol),Other,Response(s),2022-09-13T04:00:00Z,2022,9,2022-09-13T04:00:00Z,,2022-09-13T16:04:09Z,,0,0,09000064852f8d8e
FDA-1998-N-1001-0008,FDA,FDA-1998-N-1001,TEA Eligibility Determination Letter carbomer and dexpanthenol,Other,Letter(s),2020-01-27T05:00:00Z,2020,1,2020-01-27T05:00:00Z,,2020-01-27T14:00:03Z,,0,0,09000064842f5b74
FDA-1998-N-1001-0004,FDA,FDA-1998-N-1001,Ophthalmic Drug Products for Over-the-Counter Human Use; Amendment of Final Monograph,Notice,Notice of Final Rule,2019-08-26T04:00:00Z,2019,8,2019-08-26T04:00:00Z,,2019-08-26T19:19:18Z,00- 15631,0,0,09000064805a28d7
FDA-1998-N-1001-0005,FDA,FDA-1998-N-1001,Reference,Supporting & Related Material,Reference (internal unless indicated),2019-08-26T04:00:00Z,2019,8,,,2019-08-26T19:21:15Z,,0,0,09000064805a28d8
FDA-1998-N-1001-0002,FDA,FDA-1998-N-1001,Ophthalmic Drug Products for Over-The-Counter Human Use; Proposed Amendment of Final Monograph,Proposed Rule,Notice of Proposed Rulemaking (NPRM),2019-08-26T04:00:00Z,2019,8,2019-08-26T04:00:00Z,1998-05-24T03:59:59Z,2019-08-26T19:16:37Z,98-4531,0,0,09000064805a28d5
FDA-1998-N-1001-0007,FDA,FDA-1998-N-1001,Time and Extent Applications from Cumulus Pharmaceutical L. L. C.,Other,Application,2019-08-26T04:00:00Z,2019,8,2019-08-26T04:00:00Z,,2019-08-26T19:44:07Z,,0,0,0900006483ec3049
FDA-1998-N-1001-0006,FDA,FDA-1998-N-1001,Time and Extent Applications from Cumulus Pharmaceutical L. L. C.,Other,Application,2019-08-26T04:00:00Z,2019,8,2019-08-26T04:00:00Z,,2019-08-26T19:43:53Z,,0,0,0900006483ec304a
FDA-1998-N-1001-0001,FDA,FDA-1998-N-1001,Background from Regulatory Counsel Division of OTC Drug Products,Supporting & Related Material,Background Material,2019-08-26T04:00:00Z,2019,8,,,2019-08-26T19:14:49Z,,0,0,0900006483e365a2